Interest of a Diet Rich in Cajanus Cajan (Pigeon Pea) Associated With a Standardized Exercise Protocol on NLRP3 Inflammasome Expression and Weight Loss in Adult Patients With Severe Obesity.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 124
- 试验地点
- 1
- 主要终点
- Assessment of NLRP3 expression
研究概览
简要总结
Adult obesity is due to an excess of body fat. This corresponds to all the fat in the body (or adipose tissue). It is opposed to the lean mass which corresponds to the weight of muscles, organs and viscera. It is defined from the body mass index (or BMI). BMI is calculated by dividing a person's weight by their height squared.
According to these criteria, the prevalence of obesity has reached 17% of the entire adult population in mainland France (ESTENBAN 2015 study). The prevalence figures for obesity in the French overseas departments are higher than in mainland France. The latest epidemiological data available in Martinique and Guadeloupe (KANNARI 2015 study) show that approximately 60% of the adult population is overweight and 25% of the adult population is obese.
Obesity is considered a chronic disease that increases the risk of cardiovascular and metabolic complications all the more when patients have a BMI ≥ 35 kg/m2, defining severe obesity. When BMI is equal to or exceeds 40 kg/m2, obesity is said to be "morbid" and the risk of cardiovascular complications increases by about 100% to 400% depending on the type of complications. The risk of mortality increases by 50 to 100% compared to the normal weight population.
Obesity and inflammation Adipose tissue accumulates around the abdominal viscera after the fat storage capacity of the subcutaneous territories has been reached. The accumulation of visceral fat is accompanied by a low-grade inflammatory response that is responsible for the secretion of lipid derivatives and mediators toxic to the cardiovascular system and insulin sensitivity. The inflammatory response is characterized by the expression of numerous pro-inflammatory molecules synthesized by adipocytes and immunocompetent single-macrophage cells infiltrating the vascular stroma of adipose tissue. In addition, hyperglycemia and excess lipid intermediates cause the assembly of inflammasomes in the cytosol. Among them, the NLRP3 inflammasome involved in multiple human inflammatory pathologies.
Inflammation opposes weight loss, hence the need to reduce the inflammatory response to facilitate weight loss in obese people.
Pigeon pea, known for its anti-inflammatory properties, is a legume found in Creole gardens and traditionally eaten at Christmas.
The OBESICA study aims at studying the interest of consuming pigeon pea associated with regular physical activity on the inflammatory state of the body and weight loss in obese patients.
详细描述
Obesity is a generic term for excess body fat. In adults, the World Health Organization (WHO) defines overweight and obesity by a body mass index (BMI) ≥ 25 kg/m2 and 30 kg/m2, respectively. According to these criteria, the prevalence of obesity has reached 17% of the entire adult population in France (ESTENBAN 2015 study). Obesity prevalence figures in the French overseas departments are higher than in France : 60% of the adult population in Martinique and Guadeloupe is overweight and 25% of the adult population is obese (KANNARI 2015 study).
Obesity increases the risk of cardiovascular and metabolic complications even more when patients have a BMI ≥ of 35 kg/m2, defining severe obesity. When the BMI is equal to or greater than 40 kg/m2, obesity is said to be "morbid" and the risk of cardiovascular complications increases by between 100% and 400% depending on the type of complications. The risk of mortality increases in the order of 50 to 100% compared to the normal weight population. However, some individuals do not present cardio-metabolic abnormalities despite a significant excess of fat.
Several studies show that cardiovascular and metabolic complications are indeed linked to the accumulation of abdominal visceral fat.
An abdominal girth ≥ 94 cm in men and ≥ 80 cm in women defines abdominal obesity and predicts a high risk of cardiovascular complications. While in France, abdominal obesity affects about 40% of adults, it affects 47% of men and up to 70% of women in overseas territories.
The accumulation of visceral fat is accompanied by a low-grade inflammatory response that is responsible for the secretion of lipid derivatives and mediators that are toxic to the cardiovascular system and insulin sensitivity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Have a BMI ≥ 35 kg/m² (severely obese)
- •Ability, at the time of inclusion, to follow a personalized physical activity program for 24 weeks.
- •Have agreed to follow-up for up to 36 weeks
- •Be affiliated to a social security system
- •Be able to freely give informed consent (oral)
排除标准
- •Pregnant woman
- •Have a history of type 1 diabetes
- •Weight >150 kg (criterion related to the capacity of the exercise bikes used in the study)
- •History of renal disease [glomerular filtration < 30 mL/min], cardiovascular history of myocardial ischemia (ECG signs), uncontrolled hypertension [at rest; systolic blood pressure > 140 mm Hg and diastolic blood pressure > 90 mm Hg], heart failure, cardiac valvulopathy, peripheral arterial disease or arteritis, and stroke.
- •Have an auto-inflammatory or autoimmune pathology known to modify the expression of NLRP3 (cryopyrinopathies, Crohn's disease, gouty arthritis, chondrocalcinosis, arthritic diseases, type 1 diabetes, Biermer's disease, Basedow's disease, rheumatoid arthritis, systemic lupus erythematosus, sclerodermias, non-alcoholic liver steatosis, multiple sclerosis, Alzheimer's and Parkinson's diseases)
- •Have a history of recent (<6 months) infectious disease of viral, parasitic, fungal or bacterial origin known to modify the expression of NLRP3
- •Taking medication that may affect weight gain (systemic corticosteroids, psychotropic drugs, migraine medications, beta-blockers, chemotherapy, and antibiotics)
- •Have completed a personalized physical activity program in the 12 weeks prior to inclusion,
- •Have bariatric surgery scheduled within 6 months of inclusion,
- •Have a known intolerance to legume seeds
- •Have an unbalanced low-calorie diet
- •Have consumed dietary supplements containing polyphenols of the flavonoid class (green tea catechins and isoflavones from soy and legume seeds in the 3 months prior to inclusion).
研究组 & 干预措施
Standardized physical activity protocol (EXA control group)
Physical activity protocol for 24 weeks. Protocol of dietetics and food hygiene for 24 weeks.
Standardized physical activity protocol associated with the consumption of Cajanus cajan (EXACAJAN)
The EXACAJAN protocol will be continued for 24 weeks. It will combine 3 times a week with 100 grams of pigeon peas in the diet. Protocol of dietetics and food hygiene for 24 weeks.
干预措施: Standardized physical activity protocol associated with the consumption of Cajanus cajan (EXACAJAN) (Biological)
结局指标
主要结局
Assessment of NLRP3 expression
时间窗: Randomization, 6 and 9 months +/- 8 days post randomisation
Basal level variation in mRNA expression of the NLRP3 gene (coding for the NLRP3 protein subunit of the NLRP3 inflammasome), in monocytes isolated from peripheral blood. This variation will be measured by RT-qPCR (Quantitative reverse transcription PCR) and will be expressed in DNA copy number (absolute quantification) using a standard range performed with known quantities of complementary DNA, copies of the RNA of interest.
次要结局
- Weight loss assessment(Randomization, 6 and 9 months +/- 8 days post randomisation)
- mRNA expression of IL18(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Body mass index assessment(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Plasma level of the pro-inflammatory cytokines IL18(Randomization, 6 and 9 months +/- 8 days post randomisation)
- mRNA expression of caspase-1(Randomization, 6 and 9 months +/- 8 days post randomisation)
- mRNA expression of AUC(Randomization, 6 and 9 months +/- 8 days post randomisation)
- mRNA expression of IL-1β(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Plasma level of ultra-sensitive C-reactive Protein(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Plasma level of the pro-inflammatory cytokines IL-1β(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Body composition assessment(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Abdominal perimeter assessment(Randomization, 6 and 9 months +/- 8 days post randomisation)
- Hip circumference assessment(Randomization, 6 and 9 months +/- 8 days post randomisation)